Your session is about to expire
← Back to Search
Stimulant
Flupenthixol for Cocaine Use Disorder
Phase 1
Waitlist Available
Led By Walter Ling, M.D.
Research Sponsored by National Institute on Drug Abuse (NIDA)
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial Must have
M/F, ages 21-50
Be between 18 and 65 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up up to 5 years
Awards & highlights
Study Summary
This trial is testing if a drug can help reduce the effects of cocaine.
Who is the study for?
This trial is for men and women aged 21-50 who are diagnosed with cocaine dependence according to DSM-IV criteria. Participants must consent to the study's terms. Those with psychiatric disorders needing medication, acute hepatitis, pregnancy or nursing, seizure history, alcohol or sedative dependency, or other unsafe medical conditions cannot join.Check my eligibility
What is being tested?
The study tests flupenthixol's safety and its effects on cocaine use. It examines how pretreatment with flupenthixol alters the subjective experience and physical response to cocaine, focusing on dopamine D-1 receptor involvement in stimulant reinforcement.See study design
What are the potential side effects?
Potential side effects may include changes in mood or behavior due to flupenthixol's impact on brain chemistry. Cocaine can cause increased heart rate and blood pressure, restlessness, anxiety, and risk of addiction.
Eligibility Criteria
Inclusion Criteria
You may be eligible if you check “Yes” for the criteria belowSelect...
I am between 21 and 50 years old.
Timeline
Screening ~ 3 weeks3 visits
Treatment ~ Varies
Follow Up ~ up to 5 years
Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~up to 5 years
Treatment Details
Study Objectives
Outcome measures can provide a clearer picture of what you can expect from a treatment.Primary outcome measures
Characterization of study population
Cocaine
Degree of drug craving
+7 moreFind a Location
Who is running the clinical trial?
National Institute on Drug Abuse (NIDA)Lead Sponsor
2,465 Previous Clinical Trials
2,618,633 Total Patients Enrolled
Walter Ling, M.D.Principal InvestigatorFriends Research Institute, Inc.
38 Previous Clinical Trials
4,118 Total Patients Enrolled
Media Library
Eligibility Criteria:
This trial includes the following eligibility criteria:- I am currently experiencing an acute hepatitis infection.I am between 21 and 50 years old.I have a history of seizures.I am on medication for a psychiatric condition.
Frequently Asked Questions
These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.
Is the age eligibility for this experiment capped at 35 years or above?
"The enrollment criteria of this clinical trial state that the minimum age for entry is 21 and the upper limit is 50."
Answered by AI
For whom is this research study open?
"To qualify for this research, aspiring participants must have a history of cocaine use and be between 21 to 50 years old. The enrolment goal is set at 0 individuals."
Answered by AI
Does this pharmaceutical intervention have governmental endorsement?
"Due to the Phase 1 status of this clinical trial, safety has been given a score of 1 on our scale. This reflects limited data supporting both efficacy and patient security."
Answered by AI
Who else is applying?
What site did they apply to?
Friends Research Institute
What portion of applicants met pre-screening criteria?
Did not meet criteria
Why did patients apply to this trial?
Use cocaine and feel I cannot stop.
PatientReceived no prior treatments
Recent research and studies
Other Trials to Consider
Popular Categories
Share this study with friends
Copy Link
Messenger